A serum and platelet-rich plasma serotonin assay using liquid chromatography tandem mass spectrometry for monitoring of neuroendocrine tumor patients.

C. Korse,J. C. Buning-Kager,T. Linders,A. Heijboer,D. van den Broek,M. Tesselaar,O. van Tellingen,H. V. van Rossum

DOI: https://doi.org/10.1016/j.cca.2017.04.001

2017-06-01

Abstract:

What problem does this paper attempt to address?

[Surgery for acute myocardial infarction].

N. Morishige,T. Tashiro

DOI: https://doi.org/10.1201/b13552-16

Abstract:We discuss the current status and outcome of surgery for acute myocardial infarction (AMI). The optimal timing of surgical revascularization following AMI is a matter of controversy. Early surgery after an AMI involves high risk If elective surgery is possible under mechanical cardiac support cardiac artery bypass grafting (CABG) can be performed with acceptable mortality rates early after AMI. On-pump beating heart revascularization is efficacious in patients in cardiogenic shock or with unstable hemodynamics early after AMI. For postinfarct ventricular septal perforation, an infarct exclusion technique is a standard surgical procedure. For an oozing-type postinfarction left ventricular free wall rupture, a sutureless technique is effective. For papillary muscle rupture, emergent mitral valve replacement concomitant with CABG is recommended.
Microbes as a challenge to concepts of marine ecosystem analysis

W. Reichardt

DOI: https://doi.org/10.1007/BF02368344

1995-03-01

Helgoländer Meeresuntersuchungen

Abstract:
Recombinant expression of hydroxylated human collagen in Escherichia coli

Christoph Rutschmann,Stephan Baumann,Jürg Cabalzar,Kelvin B. Luther,Thierry Hennet

DOI: https://doi.org/10.1007/s00253-013-5447-z

IF: 5

2013-12-21

Applied Microbiology and Biotechnology

Abstract:Collagen is the most abundant protein in the human body and thereby a structural protein of considerable biotechnological interest. The complex maturation process of collagen, including essential post-translational modifications such as prolyl and lysyl hydroxylation, has precluded large-scale production of recombinant collagen featuring the biophysical properties of endogenous collagen. The characterization of new prolyl and lysyl hydroxylase genes encoded by the giant virus mimivirus reveals a method for production of hydroxylated collagen. The coexpression of a human collagen type III construct together with mimivirus prolyl and lysyl hydroxylases in Escherichia coli yielded up to 90 mg of hydroxylated collagen per liter culture. The respective levels of prolyl and lysyl hydroxylation reaching 25 % and 26 % were similar to the hydroxylation levels of native human collagen type III. The distribution of hydroxyproline and hydroxylysine along recombinant collagen was also similar to that of native collagen as determined by mass spectrometric analysis of tryptic peptides. The triple helix signature of recombinant hydroxylated collagen was confirmed by circular dichroism, which also showed that hydroxylation increased the thermal stability of the recombinant collagen construct. Recombinant hydroxylated collagen produced in E. coli supported the growth of human umbilical endothelial cells, underlining the biocompatibility of the recombinant protein as extracellular matrix. The high yield of recombinant protein expression and the extensive level of prolyl and lysyl hydroxylation achieved indicate that recombinant hydroxylated collagen can be produced at large scale for biomaterials engineering in the context of biomedical applications.

biotechnology & applied microbiology
Efficient Production of Hydroxylated Human-Like Collagen Via the Co-Expression of Three Key Genes in Escherichia coli Origami (DE3)

Yunping Tang,Xiuliang Yang,Baojian Hang,Jiangtao Li,Lei Huang,Feng Huang,Zhinan Xu

DOI: https://doi.org/10.1007/s12010-015-1959-6

Abstract:Mature collagen is abundant in human bodies and very valuable for a range of industrial and medical applications. The biosynthesis of mature collagen requires post-translational modifications to increase the stability of collagen triple helix structure. By co-expressing the human-like collagen (HLC) gene with human prolyl 4-hydroxylase (P4H) and D-arabinono-1, 4-lactone oxidase (ALO) in Escherichia coli, we have constructed a prokaryotic expression system to produce the hydroxylated HLC. Then, five different media, as well as the induction conditions were investigated with regard to the soluble expression of such protein. The results indicated that the highest soluble expression level of target HLC obtained in shaking flasks was 49.55 ± 0.36 mg/L, when recombinant cells were grew in MBL medium and induced by 0.1 mM IPTG at the middle stage of exponential growth phase. By adopting the glucose feeding strategy, the expression level of target HLC can be improved up to 260 mg/L in a 10 L bench-top fermentor. Further, HPLC analyses revealed that more than 10 % of proline residues in purified HLC were successfully hydroxylated. The present work has provided a solid base for the large-scale production of hydroxylated HLC in E. coli.
Analysis of Low-Frequency Electromagnetic Transients by an Extended Time-Domain Adaptive Integral Method

A. Yılmaz,Jianming Jin,E. Michielssen

DOI: https://doi.org/10.1109/TADVP.2007.895988

2007-05-29

IEEE Transactions on Advanced Packaging

Abstract:A stable and fast marching-on-in-time based integral-equation solver for analyzing low-frequency electromagnetic transients is presented. Stability and computational efficiency are achieved by using a frequency-normalized and diagonally balanced loop-tree decomposition scheme in concert with a novel fast Fourier transform (FFT)-based acceleration scheme. The proposed algorithm extends the time-domain adaptive integral method (TD-AIM) into the low-frequency regime by accelerating the computations of not only (discrete) "delayed" interactions due to fields observed one or more time steps after being generated but also "instantaneous" interactions due to fields observed less than one time step after being launched. This is realized by augmenting the four-dimensional blocked space-time FFTs in the TD-AIM recipe with three-dimensional space-only FFTs. Application of the extended TD-AIM accelerated integral-equation solver to the analysis of package geometries demonstrates its accuracy, stability, and efficiency.
Endogenous prolyl 4-hydroxylation in Hansenula polymorpha and its use for the production of hydroxylated recombinant gelatin

Eric C de Bruin,Marc W T Werten,Colja Laane,Frits A de Wolf

DOI: https://doi.org/10.1111/j.1567-1364.2002.tb00047.x

Abstract:Several yeast systems have recently been developed for the recombinant production of gelatin and collagen. Amino acid sequence-specific prolyl 4-hydroxylation is essential for the gel-forming capacity of gelatin and for the proper folding of (pro)collagen. This post-translational modification is generally considered to be absent in microbial eukaryotic systems and therefore co-expression of heterologous (human or animal) prolyl 4-hydroxylase would be required. However, we found that the well-known protein expression host Hansenula polymorpha unexpectedly does have the endogenous capacity for prolyl 4-hydroxylation. Without co-expression of a heterologous prolyl 4-hydroxylase, both an endogenous collagen-like protein and a heterologously expressed collagen fragment were found to be sequence-specifically hydroxylated.
Prokaryotic Expression and Functional Study of a Novel Recombinant Human-derived Collagen

HU Kun,CUI Fu-zhai,XU Li,WANG Heng-liang,HUANG Liu-yu

DOI: https://doi.org/10.3969/j.issn.1671-8135.2007.08.001

2007-01-01

Abstract:The DNA sequences, which originated from gene COL1A1, optimized for E.coli codon usage and contained cell adhesion domains of GER units, was amplified by RT-PCR technology from human tissue. The recombinant expression vector pET28a(+)-COL encoded the recombinant human-derived collagen (RHDC) was constructed and transformed host E.coli strain BL21(DE3)pLysS. The RHDC production was induced by the addition of IPTG and approximately 40% of the total strain proteins. RHDC could form a triple-helical structure suggested by the SDS-PAGE and Western blot analysis. Cell adhesion assay indicated that RHDC had high cell adhesive character, which makes it suitable for use as biomaterials.
A simple cost-effective methodology for large-scale purification of recombinant non-animal collagens

Yong Y Peng,Violet Stoichevska,Soren Madsen,Linda Howell,Geoff J Dumsday,Jerome A Werkmeister,John A M Ramshaw

DOI: https://doi.org/10.1007/s00253-013-5475-8

Abstract:Recently, a different class of collagen-like molecules has been identified in numerous bacteria. Initial studies have shown that these collagens are readily produced in Escherichia coli and they have been isolated and purified by various small-scale chromatography approaches. These collagens are non-cytotoxic, are non-immunogenic, and can be produced in much higher yields than mammalian collagens, making them potential new collagens for biomedical materials. One of the major drawbacks with large-scale fermentation of collagens has been appropriate scalable down-stream processing technologies. Like other collagens, the triple helical domains of bacterial collagens are particularly resistant to proteolysis. The present study describes the development and optimization of a simple, scalable procedure using a combination of acid precipitation of the E. coli host proteins, followed by proteolysis of residual host proteins to produce purified collagens in large scale without the use of chromatographic methods.
Co-expression of recombinant human prolyl with human collagen α1 (III) chains in two yeast systems

J Xu,L N Wang,C H Zhu,D D Fan,X X Ma,Y Mi,J Y Xing

DOI: https://doi.org/10.1111/lam.12447

Abstract:In this study, we co-expressed the human prolyl 4-hydroxylases (P4H) with human collagen α1 (III) (COL3A1) in an inducible system: Pichia pastoris (pPICZB), and one constitutive system: P. pastoris (pGAPZαB). The P4H catalyses the post-translational hydroxylation of proline residues in collagen strands. Conventional protein expression system such as bacteria and yeasts, which lack endogenous P4H, are not efficient for the production of recombinant collagen. In this study, the P4H gene was constructed in pGAPZαB plasmid and pPICZB plasmid respectively. These two plasmids were transformed in P. pastoris #1 that carrying COL3A1. Colony PCR analysis and sequencing after electroporation P. pastoris GS115 showed that the target gene had inserted successfully. The results of reverse transcript-qPCR, SDS-PAGE, Western blotting and LC-MS/MS analysis of the rhCOL3A1 demonstrated that the P4H was expressed successfully. Besides, it is noted that low copy number, constitutive system was suitable for hydroxylated rhCOL3A1. Significance and impact of the study: Successful co-expression of recombinant human collagen α1 (III) (rhCOL3A1) and human prolyl 4-hydroxylases (P4H) in Picha pastoris GS115, simultaneously results in the acquisition of rhCOL3A1 with hydroxylation of proline (Hyp). Further, this experiment also discusses that the high or low copy numbers and different promoters affect the Hyp degree of rhCOL3A1. Selecting more appropriate strains can express high degree Hyp of rhCOL3A1. This work will be helpful to the collagen structure study.
Temperature-Controlled Expression of a Recombinant Human-like Collagen I Peptide in Escherichia coli

Wenjie Xie,Qiqi Wu,Zhanpeng Kuang,Jianhang Cong,Qirong Zhang,Yadong Huang,Zhijian Su,Qi Xiang

DOI: https://doi.org/10.3390/bioengineering10080926

2023-08-04

Abstract:Collagen is the functional protein of the skin, tendons, ligaments, cartilage, bone, and connective tissue. Due to its extraordinary properties, collagen has a wide range of applications in biomedicine, tissue engineering, food, and cosmetics. In this study, we designed a functional fragment of human type I collagen (rhLCOL-I) and expressed it in Escherichia coli (E. coli) BL21(DE3) PlysS containing a thermal-induced plasmid, pBV-rhLCOL-I. The results indicated that the optimal expression level of the rhLCOL-I reached 36.3% of the total protein at 42 °C, and expressed in soluble form. In a 7 L fermentation, the yield of purified rhLCOL-I was 1.88 g/L. Interestingly, the plasmid, pBV220-rhLCOL-I, was excellently stable during the fermentation process, even in the absence of antibiotics. Functional analyses indicated that rhLCOL-I had the capacity to promote skin cell migration and adhesion in vitro and in vivo. Taken together, we developed a high-level and low-cost approach to produce collagen fragments suitable for medical applications in E. coli.
Web 2.0 driven Open Innovation Networks

Michael Reinhardt,M. Frieß,Georg Groh,M. Wiener,M. Amberg

Abstract:
Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms

Kalle H Sipilä,Kati Drushinin,Pekka Rappu,Johanna Jokinen,Tiina A Salminen,Antti M Salo,Jarmo Käpylä,Johanna Myllyharju,Jyrki Heino

DOI: https://doi.org/10.1074/jbc.RA118.002200

2018-05-18

Abstract:Collagens are the most abundant extracellular matrix proteins in vertebrates and have a characteristic triple-helix structure. Hydroxylation of proline residues is critical for helix stability, and diminished prolyl hydroxylase activity causes wide-spread defects in connective tissues. Still, the role of proline hydroxylation in the binding of collagen receptors such as integrins is unclear. Here, we isolated skin collagen from genetically modified mice having reduced prolyl 4-hydroxylase activity. At room temperature, the reduced proline hydroxylation did not affect interactions with the recombinant integrin α2I domain, but at 37 °C, collagen hydroxylation correlated with the avidity of α2I domain binding. Of note, LC-MS/MS analysis of isolated skin collagens revealed no major changes in the hydroxyproline content of the main integrin-binding sites. Thus, the disrupted α2I domain binding at physiological temperatures was most likely due to structural destabilization of the collagenous helix. Integrin α2I binding to the triple-helical GFPGER motif was slightly weaker than to GFOGER (O = hydroxyproline). This phenomenon was more prominent when α1 integrin was tested. Integrin α1β1 expressed on CHO cells and recombinant α1I domain showed remarkably slower binding velocity and weaker avidity to GFPGER when compared with GFOGER. Structural modeling revealed the critical interaction between Arg-218 in α1I and the hydroxyproline residue in the integrin-binding motif. The role of Arg-218 was further validated by testing a variant R218D α1I domain in solid-phase binding assays. Thus, our results show that the lack of proline hydroxylation in collagen can affect integrin binding by a direct mechanism and via structural destabilization of the triple helix.
Recombinant microbial systems for the production of human collagen and gelatin

Julio Báez,David Olsen,James W. Polarek

DOI: https://doi.org/10.1007/s00253-005-0180-x

IF: 5

2005-11-15

Applied Microbiology and Biotechnology

Abstract:The use of genetically engineered microorganisms is a cost-effective, scalable technology for the production of recombinant human collagen (rhC) and recombinant gelatin (rG). This review will discuss the use of yeast (Pichia pastoris, Saccharomyces cerevisiae, Hansenula polymorpha) and of bacteria (Escherichia coli, Bacillus brevis) genetically engineered for the production of rhC and rG. P. pastoris is the preferred production system for rhC and rG. Recombinant strains of P. pastoris accumulate properly hydroxylated triple helical rhC intracellularly at levels up to 1.5 g/l. Coexpression of recombinant collagen with recombinant prolyl hydroxylase results in the synthesis of hydroxylated collagen with thermal stability similar to native collagens. The purified hydroxylated rhC forms fibrils that are structurally similar to fibrils assembled from native collagen. These qualities make rhC attractive for use in many medical applications. P. pastoris can also be engineered to secrete high levels (3 to 14 g/l ) of collagen fragments with defined length, composition, and physiochemical properties that serve as substitutes for animal-derived gelatins. The replacement of animal-derived collagen and gelatin with rhC and rG will result in products with improved safety, traceability, reproducibility, and quality. In addition, the rhC and rG can be engineered to improve the performance of products containing these biomaterials.

biotechnology & applied microbiology
Purification of recombinant bacterial collagens containing structural perturbations

Sonal Gahlawat,Vikas Nanda,David I. Shreiber

DOI: https://doi.org/10.1371/journal.pone.0285864

IF: 3.7

2023-05-17

PLoS ONE

Abstract:Streptococcus pyogenes -derived recombinant bacterial collagen-like proteins (CLPs) are emerging as a potential biomaterial for biomedical research and applications. Bacterial CLPs form stable triple helices and lack specific interactions with human cell surface receptors, thus enabling the design of novel biomaterials with specific functional attributes. Bacterial collagens have been instrumental in understanding collagen structure and function in normal and pathological conditions. These proteins can be readily produced in E . coli , purified using affinity chromatography, and subsequently isolated after cleavage of the affinity tag. Trypsin is a widely used protease during this purification step since the triple helix structure is resistant to trypsin digestion. However, the introduction of Gly→X mutations or natural interruptions within CLPs can perturb the triple helix structure, making them susceptible to trypsin digestion. Consequently, removing the affinity tag and isolating collagen-like (CL) domains containing mutations is impossible without degradation of the product. We present an alternative method to isolate CL domains containing Gly→X mutations utilizing a TEV protease cleavage site. Protein expression and purification conditions were optimized for designed protein constructs to achieve high yield and purity. Enzymatic digestion assays demonstrated that CL domains from wild-type CLPs could be isolated by digestion with either trypsin or TEV protease. In contrast, CLPs containing Gly→Arg mutations are readily digested by trypsin while digestion with TEV protease cleaved the His6-tag, enabling the isolation of mutant CL domains. The developed method can be adapted to CLPs containing various new biological sequences to develop multifunctional biomaterials for tissue engineering applications.

multidisciplinary sciences
Incorporation of Natural and Recombinant Collagen Proteins within Fmoc-Based Self-Assembling Peptide Hydrogels

Mattia Vitale,Cosimo Ligorio,Jordi Bella,Ian P. Smith,Stephen M. Richardson,Judith A. Hoyland

DOI: https://doi.org/10.3390/gels8050254

IF: 4.6

2022-04-21

Gels

Abstract:Hydrogel biomaterials mimic the natural extracellular matrix through their nanofibrous ultrastructure and composition and provide an appropriate environment for cell–matrix and cell–cell interactions within their polymeric network. Hydrogels can be modified with different proteins, cytokines, or cell-adhesion motifs to control cell behavior and cell differentiation. Collagens are desirable and versatile proteins for hydrogel modification due to their abundance in the vertebrate extracellular matrix and their interactions with cell-surface receptors. Here, we report a quick, inexpensive and effective protocol for incorporation of natural, synthetic and recombinant collagens into Fmoc-based self-assembling peptide hydrogels. The hydrogels are modified through a diffusion protocol in which collagen molecules of different molecular sizes are successfully incorporated and retained over time. Characterization studies show that these collagens interact with the hydrogel fibers without affecting the overall mechanical properties of the composite hydrogels. Furthermore, the collagen molecules incorporated into the hydrogels are still biologically active and provide sites for adhesion and spreading of human fibrosarcoma cells through interaction with the α2β1 integrin. Our protocol can be used to incorporate different types of collagen molecules into peptide-based hydrogels without any prior chemical modification. These modified hydrogels could be used in studies where collagen-based substrates are required to differentiate and control the cell behavior. Our protocol can be easily adapted to the incorporation of other bioactive proteins and peptides into peptide-based hydrogels to modulate their characteristics and their interaction with different cell types.

polymer science
Preparation and characterization of monomers to tetramers of a collagen-like domain from Streptococcus pyogenes

Yong Y Peng,Violet Stoichevska,Linda Howell,Soren Madsen,Jerome A Werkmeister,Geoff J Dumsday,John A M Ramshaw

DOI: https://doi.org/10.4161/21655979.2014.969168

Bioengineered

Abstract:The collagen like domain Scl2 from Streptococcus pyogenes has been proposed as a potential biomedical material. It is non-cytotoxic and non-immunogenic and can be prepared in good yield in fermentation. The Scl2 collagen domain is about a quarter of the length, 234 residues, of the main collagen type, mammalian type I collagen (1014 residues) that is currently used in biomedical devices. In the present study we have made constructs comprising 1 to 4 copies of the Scl2 collagen domain, plus these same constructs with a CysCys sequence at the C-terminal, analogous to that found in mammalian type III collagens. The yields of these constructs were examined from 2 L fermentation studies. The yields of both series declined with increasing size. Circular dichroism showed that the addition of further collagen domains did not lead to a change in the melting temperature compared to the monomer domain. Addition of the CysCys sequence led to a small additional stabilization of about 2-3°C for the monomer construct when the folding (V) domain was present.
Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor

Bo An,Vittorio Abbonante,Huifang Xu,Despoina Gavriilidou,Ayumi Yoshizumi,Dominique Bihan,Richard W Farndale,David L Kaplan,Alessandra Balduini,Birgit Leitinger,Barbara Brodsky

DOI: https://doi.org/10.1074/jbc.M115.674507

2016-02-26

Abstract:A bacterial collagen-like protein Scl2 has been developed as a recombinant collagen model system to host human collagen ligand-binding sequences, with the goal of generating biomaterials with selective collagen bioactivities. Defined binding sites in human collagen for integrins, fibronectin, heparin, and MMP-1 have been introduced into the triple-helical domain of the bacterial collagen and led to the expected biological activities. The modular insertion of activities is extended here to the discoidin domain receptors (DDRs), which are collagen-activated receptor tyrosine kinases. Insertion of the DDR-binding sequence from human collagen III into bacterial collagen led to specific receptor binding. However, even at the highest testable concentrations, the construct was unable to stimulate DDR autophosphorylation. The recombinant collagen expressed in Escherichia coli does not contain hydroxyproline (Hyp), and complementary synthetic peptide studies showed that replacement of Hyp by Pro at the critical Gly-Val-Met-Gly-Phe-Hyp position decreased the DDR-binding affinity and consequently required a higher concentration for the induction of receptor activation. The ability of the recombinant bacterial collagen to bind the DDRs without inducing kinase activation suggested it could interfere with the interactions between animal collagen and the DDRs, and such an inhibitory role was confirmed in vitro and with a cell migration assay. This study illustrates that recombinant collagen can complement synthetic peptides in investigating structure-activity relationships, and this system has the potential for the introduction or inhibition of specific biological activities.
Heterologous expression, fermentation strategies and molecular modification of collagen for versatile applications

Zhi-Xiang Xiang,Jin-Song Gong,Heng Li,Wei-Ting Shi,Min Jiang,Zheng-Hong Xu,Jin-Song Shi

DOI: https://doi.org/10.1080/10408398.2021.2016599

IF: 11.208

2021-12-15

Critical Reviews in Food Science and Nutrition

Abstract:Collagen is a kind of high macromolecular protein with unique tissue distribution and distinctive functions in the body. At present, most collagen products are extracted from the tissues and organs of mammals or marine fish. However, this method exhibits several disadvantages, including low efficiency and serious waste generation, which makes it difficult to meet the current market demand. With the rapid development of synthetic biology and the deepening of high-density fermentation technology, the collagen preparation by biosynthesis strategy emerges as the times require. Co-expression with the proline hydroxylase gene can solve the problem of non-hydroxylated collagen, but the yield may be affected. Therefore, improving the expression through molecular modification and dynamic regulation of synthesis is an entry point for future research. Due to the defects in certain properties of the natural collagen, modification of properties would be benefit for meeting the requirements of practical application. In this paper, in-depth investigations on recombinant expression, fermentation, and modification studies of collagen are conducted. Also, it summarizes the research progress of collagen in food, medicine, and beauty industry in recent years. Furthermore, the future development trend and application prospect of collagen are discussed, which would provide guidance for its preparation and application.

food science & technology,nutrition & dietetics
Inhibition of yeast mitochondrial F1-ATPase, F0F1-ATPase and submitochondrial particles by rhodamines and ethidium bromide.

H. Wieker,D. Kuschmitz,B. Hess

DOI: https://doi.org/10.1016/0005-2728(87)90253-2

1987-06-09

Biochimica et Biophysica Acta

Abstract:
New strategy for expression of recombinant hydroxylated human collagen α1(III) chains in Pichia pastoris GS115

Jing He,Xiaoxuan Ma,Fenglong Zhang,Linbo Li,Jianjun Deng,Wenjiao Xue,Chenhui Zhu,Daidi Fan

DOI: https://doi.org/10.1002/bab.1264

2015-03-23

Biotechnology and Applied Biochemistry

Abstract:Type III collagen is one of the most abundant proteins in the human body, which forms collagen fibrils and provides the stiff, resilient characteristics of many tissues. In this paper, a new method for secretory expression of recombinant hydroxylated human collagen α1(III) chain in Pichia pastoris GS115 was applied. The gene encoding for full-length human collagen α1(III) chain (COL3A1) without N-terminal propeptide and C-terminal propeptide was cloned in the pPIC9K expression vector. The prolyl 4-hydroxylase (P4H, EC 1.14.11.2) α-subunit (P4Hα) and β-subunit (P4Hβ) genes were cloned in the same expression vector, pPICZB. Fluorogenic quantitative PCR indicates that COL3A1 and P4H genes have been expressed in mRNA level. SDS-PAGE shows that secretory expression of recombinant human collagen α1(III) chain was successfully achieved in P. pastoris GS115. In addition, the result of amino acids composition analysis shows that the recombinant human collagen α1(III) chain contains hydroxyproline by coexpression with the P4H. Furthermore, liquid chromatography coupled with tandem mass spectrometry analysis demonstrates that proline residues of the recombinant human collagen α1(III) chain were hydroxylated in the X or Y positions of Gly-X-Y triplets.

biotechnology & applied microbiology,biochemistry & molecular biology

A serum and platelet-rich plasma serotonin assay using liquid chromatography tandem mass spectrometry for monitoring of neuroendocrine tumor patients.

[Surgery for acute myocardial infarction].

Microbes as a challenge to concepts of marine ecosystem analysis

Recombinant expression of hydroxylated human collagen in Escherichia coli

Efficient Production of Hydroxylated Human-Like Collagen Via the Co-Expression of Three Key Genes in Escherichia coli Origami (DE3)

Analysis of Low-Frequency Electromagnetic Transients by an Extended Time-Domain Adaptive Integral Method

Endogenous prolyl 4-hydroxylation in Hansenula polymorpha and its use for the production of hydroxylated recombinant gelatin

Prokaryotic Expression and Functional Study of a Novel Recombinant Human-derived Collagen

A simple cost-effective methodology for large-scale purification of recombinant non-animal collagens

Co-expression of recombinant human prolyl with human collagen α1 (III) chains in two yeast systems

Temperature-Controlled Expression of a Recombinant Human-like Collagen I Peptide in Escherichia coli

Web 2.0 driven Open Innovation Networks

Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms

Recombinant microbial systems for the production of human collagen and gelatin

Purification of recombinant bacterial collagens containing structural perturbations

Incorporation of Natural and Recombinant Collagen Proteins within Fmoc-Based Self-Assembling Peptide Hydrogels

Preparation and characterization of monomers to tetramers of a collagen-like domain from Streptococcus pyogenes

Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor

Heterologous expression, fermentation strategies and molecular modification of collagen for versatile applications

Inhibition of yeast mitochondrial F1-ATPase, F0F1-ATPase and submitochondrial particles by rhodamines and ethidium bromide.

New strategy for expression of recombinant hydroxylated human collagen α1(III) chains in Pichia pastoris GS115